Perrigo | PRGO - Loan Capital


Perrigo reported $3.62B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Abbott USD 29.64B 19.74B Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
Coherus Biosciences USD 51.08M 496K Dec/2025
Dr.Reddys Laboratories INR 12.2B 595M Mar/2026
Eli Lilly USD 39.37B 1.5B Mar/2026
J&J USD 37.53B 1.91B Mar/2026
Merck USD 46.67B 77M Mar/2026
Nestle CHF 46.25B 742M Dec/2025
Pacira USD 367.66M 4.53M Mar/2026
Perrigo USD 3.62B 17.5M Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
Phibro Animal Health USD 597.68M 5.92M Mar/2026
Prestige Brands USD 1.01B 40.28M Mar/2026
Reckitt Benckiser GBP 7.24B 590M Dec/2024
Sanofi EUR 13.84B 1.88B Mar/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 14.02B 971M Mar/2026
Xeris Pharmaceuticals USD 221.22M 889K Mar/2026
Zoetis USD 9.04B 3M Mar/2026